Delivery Order SPE2DB22D9239-SPE2DB23FDK94
Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $34K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $17,245.40 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 mg for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from September 1st through September 5th, 2023. No set aside designation or subcontractors were identified....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $12,934 to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 MG for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from May 8-9, 2023. No subcontractors or set aside designations were identified. This...
- The Defense Logistics Agency awarded a $12,934.05 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 MG for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from July 24-25, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-four thousand four hundred ninety dollars and eighty cents ($34,490.80) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois, and the period of performance is one day from June 29, 2023 to June 30, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand seventeen dollars and fifty-four cents ($25,017.54) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) tablets of XTANDI 40 MG for prostate cancer treatment. The single order is for product delivery to a facility in Park Ridge, Illinois by June 23, 2023 with performance beginning on June 22, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand nine hundred thirty-four dollars and five cents ($12,934.05) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois and the period of performance is September 7-8, 2023. No set aside designation or subcontractors are indicated. This order is likely placed against DLA's...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $34,490.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the supply of 120 capsules of XTANDI 40 MG CAPSULE. The place of performance will be Park Ridge, Illinois and the period of performance is from August 11, 2023 through August 14, 2023. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Inc. The order is for one hundred twenty (120) capsules of the prostate cancer drug XTANDI at forty (40) milligrams per capsule. Performance will take place at the prime contractor's facility located at Park Ridge, Illinois from August 22,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Incorporated. The order is for one hundred twenty (120) capsules of the pharmaceutical product XTANDI 40 MG to be delivered to a facility located in Park Ridge, Illinois by July 31, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports...
- The Defense Logistics Agency Troop Support Medical (DLA) awarded a $4,311 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 mg capsules. DLA provides worldwide logistics support to the Department of Defense and this order for prostate cancer medication will be fulfilled from DMS's facility in Park Ridge, Illinois by July 31, 2023. No subcontractors or set aside designations were identified. This delivery order was issued under DLA's...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDK94Delivery Order
The Defense Logistics Agency awarded a $34,490.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 MG for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from July 14-17, 2023. No subcontractors or set aside designations were identified. This order supports DLA's mission to provide medical supplies and medications to military treatment facilities worldwide.
Generated 12/21/23, 10:58 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.5k | 7/14/23 |